03:21:18 EST Thu 22 Jan 2026
Enter Symbol
or Name
USA
CA



Mindbio Therapeutics Corp (2)
Symbol MBIO
Shares Issued 4,794,228
Close 2026-01-21 C$ 1.05
Market Cap C$ 5,033,939
Recent Sedar+ Documents

Mindbio Therapeutics begins trading on OTCQB

2026-01-21 19:46 ET - News Release

Mr. Justin Hanka reports

MINDBIO LISTS FOR TRADING ON OTCQB MARKET

Mindbio Therapeutics Corp. has listed its common shares for trading on the OTCQB market.

The company's listing of its common shares for trading on the OTCQB market comes as the company launches an extended road show of its voice and AI-powered (artificial intelligence) drug and alcohol intoxication technology in the United States.

In a world first, Mindbio has developed an AI model that uses over 50 million data points to predict alcohol intoxication with remarkable accuracy, just by using the human voice. The technology goes further to estimate actual blood alcohol concentration levels in the successful 2025 launch of the Booze AI app.

The company is developing an enterprise version and new platform-level technology for health prediction using the human voice and is expanding its drug and alcohol intoxication technology for use in workplace environments, call centres, mental health and law enforcement, and the company hopes to make announcements about the progress of the new technology, new products and markets, and potential commercial applications shortly.

Justin Hanka, chief executive officer of Mindbio, said, "We are pleased to now reach U.S. investors and a much larger investor audience, particularly those U.S. investors interested in AI and predictive health technologies, via our OTCQB listing."

About Mindbio Therapeutics Corp.

Mindbio Therapeutics is a biotechnology company headquartered in Vancouver, B.C., that for several years has been conducting drug and alcohol research and has created health prediction technologies using AI and machine learning. The company has expertise in using speech analytics as a prediction tool for drug and alcohol intoxication and has created a world-first voice and AI-powered prediction model for drug and alcohol intoxication for use in consumer and enterprise situations. The company is developing a comprehensive enterprise platform using voice and powered by AI for use in detecting drug and alcohol intoxication in workplaces, law enforcement, mental health and telehealth.

We seek Safe Harbor.

© 2026 Canjex Publishing Ltd. All rights reserved.